126 related articles for article (PubMed ID: 35944649)
1. Fatostatin inhibits SREBP2-mediated cholesterol uptake via LDLR against selective estrogen receptor α modulator-induced hepatic lipid accumulation.
Li M; Lu Q; Zhu Y; Fan X; Zhao W; Zhang L; Jiang Z; Yu Q
Chem Biol Interact; 2022 Sep; 365():110091. PubMed ID: 35944649
[TBL] [Abstract][Full Text] [Related]
2. Metformin treatment prevents SREBP2-mediated cholesterol uptake and improves lipid homeostasis during oxidative stress-induced atherosclerosis.
Gopoju R; Panangipalli S; Kotamraju S
Free Radic Biol Med; 2018 Apr; 118():85-97. PubMed ID: 29499335
[TBL] [Abstract][Full Text] [Related]
3. Endoplasmic Reticulum Stress and Ca2+ Depletion Differentially Modulate the Sterol Regulatory Protein PCSK9 to Control Lipid Metabolism.
Lebeau P; Al-Hashimi A; Sood S; Lhoták Š; Yu P; Gyulay G; Paré G; Chen SR; Trigatti B; Prat A; Seidah NG; Austin RC
J Biol Chem; 2017 Jan; 292(4):1510-1523. PubMed ID: 27909053
[TBL] [Abstract][Full Text] [Related]
4. Lecithin:cholesterol acyltransferase deficiency protects against cholesterol-induced hepatic endoplasmic reticulum stress in mice.
Hager L; Li L; Pun H; Liu L; Hossain MA; Maguire GF; Naples M; Baker C; Magomedova L; Tam J; Adeli K; Cummins CL; Connelly PW; Ng DS
J Biol Chem; 2012 Jun; 287(24):20755-68. PubMed ID: 22500017
[TBL] [Abstract][Full Text] [Related]
5. Identification of neolignans with PCSK9 downregulatory and LDLR upregulatory activities from Penthorum chinense and the potential in cholesterol uptake by transcriptional regulation of LDLR via SREBP2.
Chae HS; Pel P; Cho J; Kim YM; An CY; Huh J; Choi YH; Kim J; Chin YW
J Ethnopharmacol; 2021 Oct; 278():114265. PubMed ID: 34111537
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol in LDL receptor recycling and degradation.
Yang HX; Zhang M; Long SY; Tuo QH; Tian Y; Chen JX; Zhang CP; Liao DF
Clin Chim Acta; 2020 Jan; 500():81-86. PubMed ID: 31770510
[TBL] [Abstract][Full Text] [Related]
7. Fatostatin in Combination with Tamoxifen Induces Synergistic Inhibition in ER-Positive Breast Cancer.
Liu Y; Zhang N; Zhang H; Wang L; Duan Y; Wang X; Chen T; Liang Y; Li Y; Song X; Li C; Han D; Chen B; Zhao W; Yang Q
Drug Des Devel Ther; 2020; 14():3535-3545. PubMed ID: 32921987
[TBL] [Abstract][Full Text] [Related]
8. Lipid disorder and intrahepatic renin-angiotensin system activation synergistically contribute to non-alcoholic fatty liver disease.
Wu Y; Ma KL; Zhang Y; Wen Y; Wang GH; Hu ZB; Liu L; Lu J; Chen PP; Ruan XZ; Liu BC
Liver Int; 2016 Oct; 36(10):1525-34. PubMed ID: 27028410
[TBL] [Abstract][Full Text] [Related]
9. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
[TBL] [Abstract][Full Text] [Related]
10. Activation of peroxisome proliferator-activated receptor-alpha in mice induces expression of the hepatic low-density lipoprotein receptor.
Huang Z; Zhou X; Nicholson AC; Gotto AM; Hajjar DP; Han J
Br J Pharmacol; 2008 Oct; 155(4):596-605. PubMed ID: 18852694
[TBL] [Abstract][Full Text] [Related]
11. Phenytoin is an estrogen receptor α-selective modulator that interacts with helix 12.
Fadiel A; Song J; Tivon D; Hamza A; Cardozo T; Naftolin F
Reprod Sci; 2015 Feb; 22(2):146-55. PubMed ID: 25258361
[TBL] [Abstract][Full Text] [Related]
12. Selective estrogen receptor modulators (SERMs) affect cholesterol homeostasis through the master regulators SREBP and LXR.
Fernández-Suárez ME; Daimiel L; Villa-Turégano G; Pavón MV; Busto R; Escolà-Gil JC; Platt FM; Lasunción MA; Martínez-Botas J; Gómez-Coronado D
Biomed Pharmacother; 2021 Sep; 141():111871. PubMed ID: 34225017
[TBL] [Abstract][Full Text] [Related]
13. CETP inhibitors downregulate hepatic LDL receptor and PCSK9 expression in vitro and in vivo through a SREBP2 dependent mechanism.
Dong B; Singh AB; Fung C; Kan K; Liu J
Atherosclerosis; 2014 Aug; 235(2):449-62. PubMed ID: 24950000
[TBL] [Abstract][Full Text] [Related]
14. MiRNA-27a sensitizes breast cancer cells to treatment with Selective Estrogen Receptor Modulators.
Ljepoja B; García-Roman J; Sommer AK; Wagner E; Roidl A
Breast; 2019 Feb; 43():31-38. PubMed ID: 30415143
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of angiogenesis by selective estrogen receptor modulators through blockade of cholesterol trafficking rather than estrogen receptor antagonism.
Shim JS; Li RJ; Lv J; Head SA; Yang EJ; Liu JO
Cancer Lett; 2015 Jun; 362(1):106-15. PubMed ID: 25799952
[TBL] [Abstract][Full Text] [Related]
16. Human prostate cancer cells lack feedback regulation of low-density lipoprotein receptor and its regulator, SREBP2.
Chen Y; Hughes-Fulford M
Int J Cancer; 2001 Jan; 91(1):41-5. PubMed ID: 11149418
[TBL] [Abstract][Full Text] [Related]
17. Fatostatin promotes anti-tumor immunity by reducing SREBP2 mediated cholesterol metabolism in tumor-infiltrating T lymphocytes.
Zhu L; Shi Y; Feng Z; Yuan D; Guo S; Wang Y; Shen H; Li Y; Yan F; Wang Y
Eur J Pharmacol; 2024 May; 971():176519. PubMed ID: 38522641
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome Proliferator-activated receptor γ activation by ligands and dephosphorylation induces proprotein convertase subtilisin kexin type 9 and low density lipoprotein receptor expression.
Duan Y; Chen Y; Hu W; Li X; Yang X; Zhou X; Yin Z; Kong D; Yao Z; Hajjar DP; Liu L; Liu Q; Han J
J Biol Chem; 2012 Jul; 287(28):23667-77. PubMed ID: 22593575
[TBL] [Abstract][Full Text] [Related]
19. Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism.
Wang S; Sheng F; Zou L; Xiao J; Li P
J Adv Res; 2021 Dec; 34():109-122. PubMed ID: 35024184
[TBL] [Abstract][Full Text] [Related]
20. Activation of mTORC1 disrupted LDL receptor pathway: a potential new mechanism for the progression of non-alcoholic fatty liver disease.
Liu J; Ma KL; Zhang Y; Wu Y; Hu ZB; Lv LL; Tang RN; Liu H; Ruan XZ; Liu BC
Int J Biochem Cell Biol; 2015 Apr; 61():8-19. PubMed ID: 25622557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]